News | Pfizer | Pfizer

Home
News

How a Coronavirus Protease Inhibitor Works to Fight COVID-19

SARS-CoV-2, the virus that causes COVID-19, was sometimes called the “novel coronavirus” in the early days of the pandemic.

Our People

How One Woman’s Feeling of Helplessness Launched an Initiative to Hire Refugees

The images, unfortunately, have been too common for far too long: people young and old, refugees whose lives have been upended by forces beyond their control, fleeing their homes for safety.

Your Health

Are You At Risk For A Blood Clot?

NBC News war correspondent David Bloom was the image of health. In 2003, he was a 39-year-old avid tennis player.

Search More Stories

Behind the Science Features

Experience multimedia stories that give you an exciting view of Pfizer’s initiatives as we pursue breakthroughs that change patients’ lives.

Go Behind the Science

Media Resources

This information is intended for media professionals. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.

Pipeline Snapshot as of May 3, 2022

00Phase 1
00Phase 2
00Phase 3
00Registration
00Total

Download Complete Pipeline PDF

Clinical Trials

We proudly partner with thousands of study sites and tens of thousands of trial participants around the world. It’s these clinical trials that lead to life-changing medicines.

Go to Pfizer Clinical Trials Site

Our Careers

Incredible things can happen when people come together with one shared goal. The future of medicine is happening at Pfizer, and we’re eager to work alongside inspired and inspirational people who want to improve healthcare around the world.

Explore Our Careers

To Our Investors

Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere.

To Our Investors

How a Coronavirus Protease Inhibitor Works to Fight COVID-19

How One Woman’s Feeling of Helplessness Launched an Initiative to Hire Refugees

Are You At Risk For A Blood Clot?

Experience multimedia stories that give you an exciting view of Pfizer’s initiatives as we pursue breakthroughs that change patients’ lives.

February 2022

Pfizer Reports Fourth-Quarter and Full-Year 2021 Results

Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate

Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From U.S. FDA

Pfizer Announces New Chief Development Officer

Pfizer Invites Public to View and Listen to a Webcast with Pfizer Director Joseph Echevarria to Discuss Board Oversight of ESG

January 2022

European Commission Approves LORVIQUA® (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung Cancer

Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment

Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age

Pfizer and BioNTech Publish Data from Two Laboratory Studies on COVID-19 Vaccine-induced Antibodies Ability to Neutralize SARS-CoV-2 Omicron Variant

Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency

Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform

Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant

We proudly partner with thousands of study sites and tens of thousands of trial participants around the world. It’s these clinical trials that lead to life-changing medicines.

Incredible things can happen when people come together with one shared goal. The future of medicine is happening at Pfizer, and we’re eager to work alongside inspired and inspirational people who want to improve healthcare around the world.

Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere.

Why Invest

Financial Reports

Events and Presentations

Stock Information

Investor News

Shareholder Services